- ImmunoPrecise Antibodies (NASDAQ:IPA) obtained a written notification from Nasdaq, notifying them that they don’t adjust to the minimal bid worth requirement outlined within the Nasdaq Listing Rules for continued itemizing on the Nasdaq.
- The notification letter doesn’t affect the corporate’s itemizing or buying and selling of the corporate’s frequent shares on Nasdaq presently.
Source: Seekingalpha